Our Team
Many Backgrounds. Different Perspectives. Persistently Curious.
MEET THE TEAM
ADISON BECKER
Senior Executive Assistant
SEBASTIAN HUAYAMARES, PhD
Associate
ALDEN MASTERS
Human Resources Business Partner
MICHAEL SHERMAN, MD
Venture Partner
HABIB DABLE
Venture Partner
RYAN RUSSELL
Fund Accountant
ADISON BECKER
Senior Executive Assistant
Adison is a Senior Executive Assistant RA Capital Management. Adison’s primary responsibilities are to coordinate calendars, events, and company meetings for the Investment Team. Adison previously held posts as an Administrative Assistant and Office Manager at Dyer Brown Architects and as an Executive Assistant to the Principal and Office Manager at bKL Architecture. She has a BA in Communication Studies from University of Minnesota, Twin Cities.
SEBASTIAN HUAYAMARES, PhD
Associate
Sebastian Huayamares is an Associate with the TechAtlas division of RA Capital. Sebastian works closely with members of the investment team and portfolio companies to deeply understand competitive landscapes, evaluate investment opportunities in a variety of therapeutic areas across all stages from discovery and new company creation through commercialization, and advise portfolio companies on program and pipeline strategy. Prior to RA, Sebastian investigated drug delivery of RNA therapeutics as part of his PhD in biomedical engineering at Georgia Tech & Emory School of Medicine, where he also obtained an MS in quantitative & computational finance. He also gained experience in upstream bioprocessing and composites through R&D roles at Boehringer Ingelheim and the Fraunhofer IGCV Research Institute in Germany. Sebastian holds a BS in Chemical Engineering, a BA in Mathematics, and an MS in Bioengineering from the University of Kansas.
ALDEN MASTERS
Human Resources Business Partner
Alden is a Human Resources Business Partner at RA Capital Management. Alden supports the firm in its daily people operations and strategic planning to help achieve the firm’s human resource goals. Previously, Alden served as the HR Manager for Nova Ventures Group. Prior to that, she specialized in recruiting for Palantir Technologies and benefits for Bright Horizons Family Solutions. Alden holds a BA in Art History from Hamilton College and is certified by the Society for Human Resources Management.
MICHAEL SHERMAN, MD
Venture Partner
Dr. Michael Sherman serves as a Venture Partner at RA Ventures and on the faculty of the Dept of Population Medicine at Harvard Medical School. Prior to joining RAVen, he served as EVP and chief medical officer at Point32Health, formed by the merger of Harvard Pilgrim Health Care and Tufts Health Plan, two leading not-for-profit health plans insuring over 2 million members. Prior to the merger, Dr. Sherman served as chief medical officer of Harvard Pilgrim Health Care, nationally recognized for both innovation and quality. He has been widely recognized as a pioneer in bringing advances in transformational therapeutics, precision medicine, and digital therapeutics to Point32Health’s members by launching structured pilots that balance access and affordability and also generate real world evidence. Dr. Sherman holds board appointments with the Personalized Medicine Coalition, the Harvard Business School Healthcare Initiative, and NEHI (Network for Excellence in Health Innovation). Prior to joining Harvard Pilgrim in 2011, Dr. Sherman held executive roles at Humana, UnitedHealth Group, Thomson Medstat (now part of IBM Watson Health), and Da Vita, as well as several early stage companies. Before pursuing an M.B.A. at Harvard Business School, Dr. Sherman received his M.D. from Yale and practiced as a cardiac anesthesiologist. He also holds a B.A. in Anthropology and Natural Sciences and an M.S. in Biomedical Anthropology from the University of Pennsylvania.
HABIB DABLE
Venture Partner
Habib Dable is a Venture Partner at RA Ventures (RAVen), focusing on advising and supporting newcos, portfolio companies and executives within RAVen. Habib brings to RAVen nearly three decades of experience as a strategic leader in Big Pharma and emerging Biotech. Prior to joining RAVen, Habib spent five years as President and CEO at Acceleron Pharma. In this role, he propelled the company to the next stage of growth and increased shareholder value by altering the course of this formerly research-based company to prioritize innovation, speed to commercialization, and culture transformation. While at Acceleron he successfully launched the company's first blockbuster asset - REBLOZYL® - and brought in the company's lead drug - Sotatercept - prior to Acceleron's eventual sale to Merck in 2021. Prior to Acceleron, Habib held various leadership roles at Bayer AG during his ~22-year tenure with the company. As President, U.S. Pharmaceuticals at Bayer, he directed a multi-billion-dollar portfolio of products across multiple therapeutic areas (cardiovascular disease, hematology, neurology, oncology, and women's health). Prior to that, he held roles as Executive Vice President, Global Head Specialty Medicine and Vice President, Ophthalmology/Global Launch Team Head, EYLEA®. Habib received his BBA in Marketing & Finance and his MBA in International Business from University of New Brunswick. He completed the Executive Program at Stanford University, Graduate School of Business, as well as the Executive to Leader Institute at Korn/Ferry International. Habib has earned his Director Professionalism® Certificate from the National Association of Corporate Directors.
RYAN RUSSELL
Fund Accountant
Ryan Russell is a Fund Accountant at RA Capital Management. His primary responsibilities are to assist with accounting, financial reporting and investment valuation. Prior to RA, Ryan was at KPMG where he was a Senior Associate. Prior to KPMG, Ryan worked at Morris and Morris, P.C. as a Staff Accountant. Ryan has a BS in Business Administration with a concentration in Accounting and Sports Management from Isenberg School of Management at University of Massachusetts, Amherst.